• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIODYNAMICS, INC. ANGIOVAC; CARDIOPULMONARY BYPASS VASCULAR CANNULA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIODYNAMICS, INC. ANGIOVAC; CARDIOPULMONARY BYPASS VASCULAR CANNULA Back to Search Results
Catalog Number H965251860
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problems Pulmonary Embolism (1498); Low Blood Pressure/ Hypotension (1914)
Event Date 11/19/2015
Event Type  Injury  
Manufacturer Narrative
Although no sample device will be returned for evaluation, the investigation into this event is ongoing.Upon completion of the investigation, a supplemental medwatch will be submitted.
 
Event Description
As reported, by angiodynamics clinical specialist regarding an angiovac procedure of the ivc and iliac vein clot: "after clearing most of the clot out of the ivc and both iliac veins, the patient became hypotensive and eventually cpr was initiated.A pe was suspected and the patient was placed on ecmo.After 20 minutes of cpr, the patient stabilized and was moved to the icu for observation".There was no indication of malfunction on the part of the angiovac.No device sample is expected to be returned.
 
Manufacturer Narrative
The reported packaging lot 4876626d for angiovac cannula item # h965251860 had a purchased angiovac cannula component packaged in it.A review of the device history records was performed by the supplier, (b)(4), for the indicated packaging and component lots for any deviations related to the reported defect of the complaint.The review confirms that the lots met all material, assembly and performance specifications.The angiodynamics complaint report was reviewed for the angiovac product family and the failure mode "patient injury / death." no adverse trend was identified.The angiovac cannula sample was not returned for evaluation since there was no reported device failure.Therefore, it cannot be determined if the cannula was used in accordance with its labeling.Directions for use is provided with this device and contains the following statements: "warnings -- selection of the patient as a candidate for use with this device and for such procedures as it is intended is the physicians' sole responsibility.The outcome is dependent on many variables including, patient pathology, surgical procedure, and perfusion procedure/technique.The benefits of use of this device must be weighed against the risks including risks of systemic anticoagulation and must be assessed by the prescribing physician.As with all medical devices, this device and ancillary equipment are to be used by trained physicians only.Specifically, this device is to be used only by medical personnel experienced with initiating and monitoring extracorporeal bypass and by physicians trained and experienced using surgical and/or percutaneous (seldinger) vascular access techniques." and "adverse events: this device, as do all extracorporeal blood vessel devices, has possible side effects, which include but are not limited to infections, blood loss, thrombus formation, embolic events, vessel, ventricular or valvular damage and complications of percutaneous or surgical insertion techniques.These may occur if the instructions for use are not followed.Possible complications include those normally associated with large bore surgical and/or percutaneous vessel catheterization/cannulation, anticoagulation, extracorporeal circulation and application of intravascular introducer systems which include but are not limited to: death, pulmonary embolism." the end user hospital reported that there was a patient adverse event (cardiac complications as a result of pe) during the angiovac procedure, but they did not report a device malfunction.No sample was returned for evaluation.The likely root cause of the adverse event is operational context within the procedure as a pe is an anticipated complication as referenced in the dfu.(b)(4).Device not returned to manufacturer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ANGIOVAC
Type of Device
CARDIOPULMONARY BYPASS VASCULAR CANNULA
Manufacturer (Section D)
ANGIODYNAMICS, INC.
marlborough MA
Manufacturer (Section G)
ANGIODYNAMICS
26 forest street
marlborough MA 01752
Manufacturer Contact
law ryan
10 glens falls technical park
glens falls, NY 12801
5187424488
MDR Report Key5326429
MDR Text Key34418879
Report Number2952363-2015-00011
Device Sequence Number1
Product Code DWF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K142593
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/19/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/30/2017
Device Catalogue NumberH965251860
Device Lot Number4876626D
Other Device ID NumberANGIOVAC
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 11/19/2015
Initial Date FDA Received12/17/2015
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received07/05/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/01/2015
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-